Phase I trial of histone deacetylase inhibitor panobinostat in addition to glucocorticoids for primary therapy of acute graft-versus-host disease

Phase I trial of histone deacetylase inhibitor panobinostat in addition to glucocorticoids for primary therapy of acute graft-versus-host diseasePhase I trial of histone deacetylase inhibitor panobinostat in addition to glucocorticoids for primary therapy of acute graft-versus-host disease, Published online: 18 April 2018; doi:10.1038/s41409-018-0163-zPhase I trial of histone deacetylase inhibitor panobinostat in addition to glucocorticoids for primary therapy of acute graft-versus-host disease

Source: Bone Marrow Transplantation - April 18, 2018 Category: Hematology Authors: Lia Perez Hugo Fernandez Pedro Horna Marcie Riches Frederick Locke Teresa Field John Powers Eva Sahakian Alejandro Villagra Asmita Mishra Brian Betts Mohamed Kharfan-Dabaja Francisca Beato Leonel Ochoa-Bayona Joseph Pidala Claudio Anasetti Source Type: research